Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

2021 ASCO GU Cancers Symposium CARD trial, cabazitaxel treatment demonstrated significantly improved progression-free survival (rPFS) and overall survival (OS), assessing the role of circulating...

ASCO GU 2021 Genitourinary Cancers Symposium Cabazitaxel second-line chemotherapy setting, feasibility and efficacy of cabazitaxel in patients with...

ASCO GU 2021 Genitourinary Cancers Symposium Cabazitaxel second-line chemotherapy setting, feasibility and efficacy of cabazitaxel in patients with...